|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0009462,
umls-concept:C0039711,
umls-concept:C0065839,
umls-concept:C0246415,
umls-concept:C0282564,
umls-concept:C0441655,
umls-concept:C0542559,
umls-concept:C0596545,
umls-concept:C0600688,
umls-concept:C0699967,
umls-concept:C1274040,
umls-concept:C1442162,
umls-concept:C1550718,
umls-concept:C1708063,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-12-22
|
|
pubmed:abstractText |
The TEXAS (Taxotere EXperience with Anthracyclines Study) study examined docetaxel in combination with an anthracycline, as first line treatment of metastatic breast cancer (MBC), in everyday practice, and compared the findings with a randomised controlled trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
413-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17009036-Adenocarcinoma,
pubmed-meshheading:17009036-Adult,
pubmed-meshheading:17009036-Aged,
pubmed-meshheading:17009036-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17009036-Breast Neoplasms,
pubmed-meshheading:17009036-Disease Progression,
pubmed-meshheading:17009036-Doxorubicin,
pubmed-meshheading:17009036-Epirubicin,
pubmed-meshheading:17009036-Female,
pubmed-meshheading:17009036-Great Britain,
pubmed-meshheading:17009036-Hospitals, Community,
pubmed-meshheading:17009036-Humans,
pubmed-meshheading:17009036-Middle Aged,
pubmed-meshheading:17009036-Survival Rate,
pubmed-meshheading:17009036-Taxoids
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
TEXAS (Taxotere EXperience with Anthracyclines Study) trial: mature results of activity/toxicity of docetaxel given with anthracyclines in a community setting, as first line therapy for MBC.
|
|
pubmed:affiliation |
South West Wales Cancer Institute, University of Wales, Wales, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
